REMEGEN (09995) spent approximately 3.0485 million yuan to repurchase about 28,000 shares on August 3.
Rongchang Biotechnology (09995) announced that on August 3, 2026, it spent approximately 3.0485 million yuan to repurchase about 28,000 shares.
REMEGEN (09995) announced that on August 3, 2026, it spent approximately 3.0485 million yuan to repurchase about 28,000 shares.
Related Articles
The demand for AI infrastructure is strong! KKR (KKR.US) has successfully raised a record $19.2 billion for its infrastructure fund, fully betting on data centers and energy transformation.
CIPRUN TECH (01020) has issued 180 million shares according to the share incentive plan.
Zhi Yuan discloses the board of directors and partners; the core team for the IPO is revealed for the first time.
The demand for AI infrastructure is strong! KKR (KKR.US) has successfully raised a record $19.2 billion for its infrastructure fund, fully betting on data centers and energy transformation.
CIPRUN TECH (01020) has issued 180 million shares according to the share incentive plan.
Zhi Yuan discloses the board of directors and partners; the core team for the IPO is revealed for the first time.
RECOMMEND
